Skip to main content

Sponsor Zone

HIC-Vac would like to thank the Sponsors who have generously contributed further funding for our 2024 Annual Meeting. Some have provided support that has been instrumental in allowing us to expand the meeting, so that we can facilitate more networking, cross-collaboration and learning among each other. Others have supported the attendance of the wonderful set of speakers who will share their expertise and research to you all. 

 

 

GOLD SPONSOR: Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer_NewsLinkedInYouTube and like us on Facebook at www.facebook.com/Pfizer/.

 

 

Seqirus

SPEAKER SUPPORT SPONSOR: Seqirus

 

CSL Seqirus is part of CSL (ASX: CSL). As a global leader in the protection of public health and one of the largest influenza vaccine providers in the world, CSL Seqirus is committed to preventing infectious diseases, like influenza and COVID-19, and is a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R&D capabilities, CSL Seqirus offers a broad portfolio of innovative, differentiated vaccines in more than 20 countries around the world. 
 
For more information about CSL Seqirus, visit CSL.com

 

Become a member now

Click below to find out how to become a member.

Register